EU Authorities Clear Invitrogen, ABI Merger | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen and Applied Biosystems today said that European Union regulatory authorities have cleared their proposed $6.7 billion merger.
 
The deal already cleared US antitrust hurdles and is expected to close on Nov. 21, the firms said.
 
ABI stockholders have until the end of the business day on Nov. 19 to elect whether they will receive all cash, all stock, or a mix of the two in consideration for their shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.